Literature DB >> 8901529

Protein phosphatase type-1 and glycogen bind to a domain in the skeletal muscle regulatory subunit containing conserved hydrophobic sequence motif.

J Wu1, U Kleiner, D L Brautigan.   

Abstract

This study identifies a 100-residue domain within the rabbit skeletal muscle regulatory subunit (PP1G) that binds both type-1 protein phosphatase (PP1C) and glycogen. An N-terminal portion of PP1G was cloned by RT-PCR, and different sized fragments were expressed in bacteria as glutathione S-transferase (GST) fusion proteins. A GST-PP1G fusion containing residues 51-240 bound both PPIC and glycogen, whereas GST alone or fusions containing residues 51-140 or 241-360 bound neither PP1C nor glycogen. The PPIC in whole cell lysates or partially purified PP1C from skeletal muscle, or a complex of PP1C-MCLR-biotin, all bound more effectively than Mn(2+)-activated, recombinant PP1C purified from bacteria. Binding was enhanced by increasing the ionic strength and was disrupted by ethylene glycol, consistent with hydrophobic interactions being critical for stable association. Phosphorylation of the GST-PP1G fusion by cAMP-dependent protein kinase prevented completely association of PP1C. This domain of PP1G, from residues 141-240, contains two sequence motifs of hydrophobic residues: Gx8FEKx10W and DxFxFxIxL, that are conserved among the known glycogen-binding PP1 regulatory subunits. These segments are predicted to form an alpha helix and a beta sheet, and we propose that they are the sites for association with PP1C and glycogen, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901529     DOI: 10.1021/bi961669e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Mutations of the serine phosphorylated in the protein phosphatase-1-binding motif in the skeletal muscle glycogen-targeting subunit.

Authors:  J Liu; J Wu; C Oliver; S Shenolikar; D L Brautigan
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Structure of the human glycogen-associated protein phosphatase 1 regulatory subunit hGM: homology modeling revealed an (alpha/beta)8-barrel-like fold in the multidomain protein.

Authors:  M Souchet; M Legave; N Jullian; H O Bertrand; A Bril; I Berrebi-Bertrand
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

3.  Molecular basis for the modulation of native T-type Ca2+ channels in vivo by Ca2+/calmodulin-dependent protein kinase II.

Authors:  Junlan Yao; Lucinda A Davies; Jason D Howard; Scott K Adney; Philip J Welsby; Nancy Howell; Robert M Carey; Roger J Colbran; Paula Q Barrett
Journal:  J Clin Invest       Date:  2006-08-17       Impact factor: 14.808

4.  Characterization of the interaction between DARPP-32 and protein phosphatase 1 (PP-1): DARPP-32 peptides antagonize the interaction of PP-1 with binding proteins.

Authors:  Y G Kwon; H B Huang; F Desdouits; J A Girault; P Greengard; A C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A.

Authors:  K Murata; J Wu; D L Brautigan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

6.  Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction.

Authors:  Alexander Khromov; Nandini Choudhury; Andra S Stevenson; Avril V Somlyo; Masumi Eto
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

7.  Protein Scaffolds Control Localized Protein Kinase Cζ Activity.

Authors:  Irene S Tobias; Alexandra C Newton
Journal:  J Biol Chem       Date:  2016-05-03       Impact factor: 5.157

8.  Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.

Authors:  J Liu; T D Prickett; E Elliott; G Meroni; D L Brautigan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

9.  A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice.

Authors:  David B Savage; Lanmin Zhai; Balasubramanian Ravikumar; Cheol Soo Choi; Johanna E Snaar; Amanda C McGuire; Sung-Eun Wou; Gemma Medina-Gomez; Sheene Kim; Cheryl B Bock; Dyann M Segvich; Bhavana Solanky; Dinesh Deelchand; Antonio Vidal-Puig; Nicholas J Wareham; Gerald I Shulman; Fredrik Karpe; Roy Taylor; Bartholomew A Pederson; Peter J Roach; Stephen O'Rahilly; Anna A DePaoli-Roach
Journal:  PLoS Med       Date:  2008-01-29       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.